A randomized, controlled, multicenter trial was undertaken in 102 patients with objective evidence of severe acute pancreatitis to evaluate whether selective decontamination reduces mortality.
Summary Background Data
Secondary pancreatic infection is the major cause of death in patients with acute necrotizing pancreatitis. Controlled clinical trials to study the effect of selective decontamination in such patients are not available.
Methods
Between April 22, 1990 and April 19, 1993 , 102 patients with severe acute pancreatitis were admitted to 16 participating hospitals. Patients were entered into the study if severe acute pancreatitis was indicated, on admission, by multiple laboratory criteria (Imrie score 2 3) and/or computed tomography criteria (Balthazar grade D or E). Patients were randomly assigned to receive standard treatment (control group) or standard treatment plus selective decontamination (norfloxacin, colistin, amphotericin; selective decontamination group). All patients received full supportive treatment, and surveillance cultures were taken in both groups.
Results
Fifty patients were assigned to the selective decontamination group and 52 were assigned to the control group. There were 18 deaths in the control group (35%), compared with 1 1 deaths (22%) in the selective decontamination group. (adjusted for Imrie score and Balthazar grade: p = 0.048). This difference was mainly caused by a reduction of late mortality (>2 weeks) due to significant reduction of gram-negative pancreatic infection (p = 0.003). The average number of laparotomies per patient was reduced in patients treated with selective decontamination (p < 0.05). Failure of selective decontamination to prevent secondary gram-negative pancreatic infection with subsequent death was seen in only three patients (6%) and transient gram-negative pancreatic infection was seen in one (2%). In both groups of patients, all gram-negative aerobic pancreatic infection was preceded by colonization of the digestive tract by the same bacteria.
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Conclusion
Reduction of gram-negative colonization of the digestive tract, preventing subsequent pancreatic infection by means of selective decontamination, significantly reduces morbidity and mortality in patients with severe acute necrotizing pancreatitis.
Despite improvement in surgical strategies, the mortality of patients with acute necrotizing pancreatitis remains high, between 20% and 70%.1-8 Infection of pancreatic necrosis is the most important cause of late mortality in severe acute pancreatitis.37,9-'3 The value of prophylactic antibiotics has not been clearly demonstrated in patients with severe acute pancreatitis and possibly is due to patient selection, inadequate spectrum, insufficient doses, or tissue penetration.12"14-'7 Patients randomized to the selective decontamination group received the same treatment as the control group with the addition of selective decontamination. The selective decontamination regimen consisted of oral administration of colistin sulfate (200 mg), amphotericin (500 mg) and norfloxacin (Noroxin, Merck & Co., West Point, PA; 50 mg) every 6 hours. A sticky paste containing 2% of the three selective decontamination drugs was smeared along the upper and lower gums every 6 hours and at the tracheostomy, if present. The aforementioned daily dose also was given in a rectal enema every day. A short-term systemic prophylaxis of cefotaxime sodium (Claforan, Hoechst-Roussel Pharm., Inc., Somerville, NJ; 500 mg) was given every 8 hours until gram-negative bacteria were eliminated from the oral cavity and rectum. Selective decontamination was discontinued as soon as the risk of acquiring a new infection was absent-i.e., the patient was extubated and without supplementary oxygen therapy or infusions, on regular oral diet, and mobilized on the ward.
Statistical Analysis
Power calculations at the phase of trial design, assuming a decrease in mortality from 50% to 25%, led to a total number of 154 patients to be included (alpha = 0.05 [two-sided] and beta = 0.10).
Because the annual accrual rate was much less than expected, after 2 years it was decided to limit the size of the trial to 100 evaluable patients, thereby reducing the power to 80% at one-sided testing. This Of the 109 patients randomized into the study, 2 (selective decontamination: n = 1; control: n = 1) were excluded because ofperioperatively proven infected necrosis immediately (< 1 hour) after randomization and before treatment was started. In addition, five patients (selective decontamination: n = 3; control: n = 2) were withdrawn from the study because the clinical diagnosis was found to be erroneous (one patient with streptococcal sepsis, one patient with an acute aortic occlusion immediately after coronary bypass surgery, one patient with a ruptured pancreatic pseudocyst, one patient with chronic pancreatitis, and one patient with an endoscopic retrograde cholangiopancreatograpy-induced choledochus perforation). Ofthe remaining 102 patients, 50 had been assigned to the selective decontamination group and 52 to the control group. Inclusion scores are listed in Table 2 . Selective decontamination was started within 24 hours of randomization. Ten patients (selective decontamination: n = 8; control: n = 2) with severe acute pancreatitis had to be randomized only on the basis of the multiple laboratory criteria (Imrie score 2 3) because their condition did not permit transport from the intensive care unit to the CT scanner at that time. Of these patients, fluid collections in or adjacent to the severely inflamed pancreas (personal communication with the attending surgeon immediately postoperatively) were demonstrated on the first day of the study during laparotomy in eight patients and with abdominal ultrasound in one patient. Because of these results, the Balthazar grade was classified as grade E. In the other patient (control group; Imrie score = 3), a CT scan was performed only after 5 days of treatment, and it demonstrated a peripancreatic fluid collection. The latter patient also underwent surgery on the first day after randomization; however, the pancreatic loge was left untouched. The Balthazar grade at the time of randomization was unavailable for this patient.
Comparability of Control and Selective Decontamination Group
Both treatment groups appeared well matched for age, sex, etiologic factors, Imrie score, and Balthazar grade. Characteristics for both groups are listed in 
Mortality
Eleven patients (22%) in the selective decontamination group died as compared with 18 patients (35%) in the control group. This difference is not significant (p = 0.19). The 95% confidence limits of the difference (control group minus selective decontamination group) in mortality ranges from less than 4% to more than 30%. Survival according to treatment group is shown in Figure  1 . All deaths occurred within 80 days. In each of both groups, six patients died of multiple-organ failure with documented sterile pancreatic necrosis. Ten patients in the control group died ofa gram-negative pancreatic sepsis syndrome compared with only three such patients in the selective decontamination group (p = 0.07). In each The Imrie score at entry into the study appeared to correlate very strongly with mortality (Fig. 2) . Mortality was 0%, for an Imrie score of 0 or 1, and it gradually increased to 100%, for patients with an Imrie score of 7 (Ptrend < 0.001). Mortality also increased with increasing Balthazar grade, although these differences were less pronounced (Ptrend = 0.04) (Fig. 2) . The worsening of prognosis with increasing Imrie score and Balthazar grade was apparent in each separate treatment group. Overall mortality in the selective decontamination group versus the mortality in the control group appeared to be significantly lower (p = 0.048), using multivariate analysis allowing for Imrie score and Balthazar grade (Table 3) . This analysis also demonstrates the importance of the Imrie score in predicting mortality. There was no significant relation between mortality and the Balthazar grade. Micro-organisms may occur in combinations in each separate patient.
Qualitative bacteriologic analysis of (peri-) pancreatic necrosis for both groups is demonstrated in Table 4 . Of 74 bacterial colonies isolated from 20 patients ofthe control group, 61% were aerobic gram-negative pathogens. Of28 colonies isolated from nine patients ofthe selective decontamination group, 21 % were aerobic gram-negative. Any case ofgram-negative pancreatic infection was preceded by intestinal colonization with identical gramnegative flora in both groups, as learned from surveillance cultures of the digestive tract.
Selective Decontamination Regimen: Complications and Failure of Selective Decontamination Because of Resistance There were no noticeable allergies in the selective decontamination regimen, and none of the deaths in the selective decontamination group were attributable to the selective decontamination regimen. Oral paste and rectal enemas were well tolerated. Gram-negative colonization of the digestive tract was successfully prevented in 46 of 50 patients (92%) of the selective decontamination group. However, failure of selective decontamination to prevent gram-negative colonization ofthe digestive tract with subsequent infection ofpancreatic necrosis with the same gram-negative bacteria was seen in 4 of 50 patients (8%). Three ofthese patients died after 9, 37, and 40 days due to resistant strains ofPseudomonas aeruginosa (two patients) and Klebsiella (one patient). Escherichia coli (< 1+) was isolated only once from pancreatic necrosis in one of these patients at the end of the first week because of initial persistence ofintestinal E. coli. Transient gram-negative pancreatic infection during selective decontamination treatment was seen in one patient-i.e., P. aeruginosa (< 3 days), followed by Serratia marcescens (< 18 days)-who was later discharged after 106 days.
Surgery and Surgery-Related Morbidity
In the control group, an average of 3.1 laparotomies were performed per patient in contrast to only 0.9 in the selective decontamination group (p < 0.05; Table 5 ). A laparostomy, whenever repeated necrosectomy was foreseen, was created in 50% of the patients in both groups. In the control group, surgical complications were seen in nine patients, compared with four patients of the selective decontamination group, who had undergone surgery less frequently (p = 0.50, NS).
Median hospital stay in patients who survived was 30 days (range 10-106 days) in the selective decontamination group compared with 32 days (range 6-241 days) in the control group (p = 0.65, NS). 
